title: Seeking ethical designs for HIV clinical trials in treatment-experienced patients: an industry perspective.
authors.affiliation: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Mayers
authors.forename: Jain
authors.initials: J
authors.lastname: Chung
authors.forename: Veronika M
authors.initials: VM
authors.lastname: Kohlbrenner
authors.forename: David B
authors.initials: DB
authors.lastname: Hall
authors.forename: Ralph A
authors.initials: RA
authors.lastname: DeMasi
authors.forename: Dietmar
authors.initials: D
authors.lastname: Neubacher
authors.forename: Neil E
authors.initials: NE
authors.lastname: Buss
authors.forename: Miklos P
authors.initials: MP
authors.lastname: Salgo
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards; D004345:Drug Industry / Q000941:ethics* / Q000458:organization & administration; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D012107:Research Design
chemical_list: D019380:Anti-HIV Agents